chemXplore tracks 8 projects in Korea (South), of which 6 are active.
Of the active ones, 2 new construction, 2 expansion and 1 conversion / repurposing.
1 active project carries no start-up date yet. The dates themselves, per project, are for subscribers.
Industry investment and policy support sustain demonstrations across blast‑furnace retrofits, DRI–ESF, and electrochemical routes while economics and infrastructure shape deployment timing.
Five startups selected to convert recycled plastics and industrial by-products into market-ready products; support includes funding, mentoring, acceleration and sales-channel aid.
Improved export margins and record lubricants profits drove quarter; battery unit loss narrowed despite lower sales, while ESS orders and LFP supply deals in North America strengthen outlook.
ESS met strengthened UL 9540A large-scale-fire criteria; no thermal runaway in adjacent container; SK On will push global ESS expansion and convert 3 GWh to LFP lines.
Independent audit confirmed the fiscal‑2025 product carbon footprint for acrylonitrile at the Ulsan plant, covering raw materials through production and exceeding limited‑assurance standards.
Upstream work finished at a 4,000 m Argentina site, raising commercial carbonate output to 48,000 t/year and enabling a 50,000 t/year lithium hydroxide system when linked to a 2027 downstream plant.
Long-term deal more than doubles prior volumes, expands supply from NCA to LFP, LMO and synthetic graphite, and secures non‑PFE materials for buyers.
HyREX demo (300,000 t/yr by 2028) in Pohang; TIMUP public‑private plan; targets KRW 6 trillion, 14,000 jobs and 560,000 t/yr CO2 reduction in the Southeastern cluster.
Post‑hoc ATTAIN‑1 modelling: oral orforglipron cut predicted 10‑year type 2 diabetes risk up to 57% and cardiovascular risk up to 18% versus placebo at 72 weeks.
Once‑daily oral GLP‑1 cut MACE vs insulin glargine, lowered A1C by 1.6% at 52 weeks and produced mean weight loss of 8.1 kg with durable effects to 104 weeks.
